This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
- A new gene essential for nuclear reprogramming identified
05.06.2013
Researchers are still fascinated by the idea of the possibility of reprogramming the cells of any tissue, turning them into cells with the capacity to differentiate into cells of a completely different type— pluripotent cells—and they are still striving to understand how it happens. A group from the Spanish National Cancer Research Centre (CNIO), headed […] - CNIO hosts an international meeting on the latest advances in genomic instability and cancer
27.05.2013
The Spanish National Cancer Research Centre (CNIO) hosts today, until May 29, an international meeting of experts to exchange ideas on the latest advances in the filed of aneuploidy—the loss or gain of chromosomes—and genomic instability, and their relationship to human disease such as cancer. The meeting is part of CNIO’s Frontiers Meeting: Chromosome Instability […] - CNIO joins the laboratory on wheels Movilab
08.05.2013
The Spanish National Cancer Research Centre (CNIO) has boarded the science truck Movilab this morning Wednesday, May 8, to raise awareness about cancer research among young people. The mobile science lab, which will visit up to 15 cities this year, will be stationed in the premises of the Instituto Carlos III until next May 10th.The […] - María Blasco, Honorary Award by the Cátedra Real Madrid
07.05.2013
María Blasco, Director of the Spanish National Cancer Research Centre (CNIO), received yesterday -by the hands of Nobel laureate Mario Vargas Llosa- an Honorary Award from the Cátedra Real Madrid in recognition for her outstanding scientific career. The event took place during the presentation ceremony of the Cátedra Real Madrid Research Grants by the University […] - First genetic factor in prostate cancer prognosis identified
09.04.2013
Patients with prostate cancer and hereditary mutations in the BRCA2 gene have a worse prognosis and lower survival rates than do the rest of the patients with the disease. This is the main conclusion to come out of a study published this week in the Journal of Clinical Oncology, in which David Olmos, Head of […] - ‘Science Careers’ devotes an article to the profile of Fátima Al-Shahrour in its ‘careers’ section
01.04.2013
The scientific researcher Fátima Al-Shahrour, head of the Translational Bioinformatics Unit in the Clinical Research program at the Spanish National Cancer Research Center (CNIO), is the focus of an article in the latest edition of the journal Science, in its Science Careers section, aimed at providing role models to young scientists.The article, entitled Applying Bioinformatics […] - An international study identifies new DNA variants that increase the risk for breast, prostate and ovarian cancers
27.03.2013
The European Collaborative Oncological Gen-Environmental Study (COGS) project, whose main goal is to decipher the complex genetic bases of breast, prostate and ovarian cancers, publishes today a total of 13 research articles in several prestigious journals, including Nature Genetics, Nature Communications, The American Journal of Human Genetics and PLOS Genetics. Using mass sequencing techniques, the […] - Molecular coordination in evolution: A review in ‘Nature Reviews Genetics’
05.03.2013
Spanish National Cancer Research Centre (CNIO) researchers Alfonso Valencia, Director of the Structural Biology and Biocomputing Programme and David de Juan, jointly with Florencio Pazos, from the Spanish National Centre for Biotechnology (CNB-CSIC), will today publish a review on the latest computational methods that, based on evolutionary principles, are revolutionising the field of analysis and […] - María Blasco becomes an Honorary Ambassador of the Spain Brand
13.02.2013
Maria Blasco E Director of the Spanish National Cancer Research Centre (CNIO) and Head of the Centre’s Telomeres & Telomerase Group E was awarded the accreditation of Honorary Ambassador of the Spain Brand, in the Science and Innovation category, in its fifth edition. The Awards Ceremony took place yesterday at Banco Santander’s Ciudad Financiera and […]